SC 13D/A 1 anpiedgar013009v3.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. ________)* ANGIOTECH PHARMACEUTICALS INC (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 034918102 (CUSIP Number) Interinvest Corporation 192 South Street, Suite 350 Boston, MA 02111 Attention: Stanley T. Schmidt Telephone: (617-723-7870) Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 29, 2009 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d- 1(g), check the following box. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1. Names of Reporting Persons. Interinvest Corporation Inc. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) x 3. SEC Use Only 4. Source of Funds (See Instructions) OO 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization Massachusetts Number of Shares Beneficially Owned by Each Reporting Person With: 7. Sole Voting Power 0 8. Shared Voting Power 1,572,150 9. Sole Dispositive Power 0 10. Shared Dispositive Power 1,572,150 11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,572,150 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 1.85% 14. Type of Reporting Person (See Instructions) IA 1. Names of Reporting Persons. Interinvest Consulting Corporation of Canada Limited 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) x 3. SEC Use Only 4. Source of Funds (See Instructions) OO 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ? 6. Citizenship or Place of Organization Canada Number of Shares Beneficially Owned by Each Reporting Person With: 7. Sole Voting Power 0 8. Shared Voting Power 2,582,700 9. Sole Dispositive Power 0 10. Shared Dispositive Power 2,582,700 11. Aggregate Amount Beneficially Owned by Each Reporting Person 2,582,700 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) 13. Percent of Class Represented by Amount in Row (11) 3.03% 14. Type of Reporting Person (See Instructions) IA 1. Names of Reporting Persons. Interinvest (Bermuda) Ltd. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) x 3. SEC Use Only 4. Source of Funds (See Instructions) OO 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization Bermuda Number of Shares Beneficially Owned by Each Reporting Person With: 7. Sole Voting Power 0 8. Shared Voting Power 1,061,000 9. Sole Dispositive Power 0 10. Shared Dispositive Power 1,061,000 11. Aggregate Amount Beneficially Owned by Each Reporting Person 1,061,000 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ? 13. Percent of Class Represented by Amount in Row (11) 1.25% 14. Type of Reporting Person (See Instructions) IA 1. Names of Reporting Persons. Hans P. Black 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) x 3. SEC Use Only 4. Source of Funds (See Instructions) OO 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) 6. Citizenship or Place of Organization Canada Number of Shares Beneficially Owned by Each Reporting Person With: 7. Sole Voting Power 0 8. Shared Voting Power 5,295,850 9. Sole Dispositive Power 0 10. Shared Dispositive Power 5,295,850 11. Aggregate Amount Beneficially Owned by Each Reporting Person 5,295,850 12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ? 13. Percent of Class Represented by Amount in Row (11) 6.22% 14. Type of Reporting Person (See Instructions) IN ITEM 1. SECURITY AND ISSUER This statement relates to the Common Stock, no par value (the "Common Stock"), of Angiotech Pharmaceuticals, Inc. (the "Issuer") with principal executive offices located at 1618 Station Street, Vancouver, B.C. Canada, V6A 1B6. ITEM 2. IDENTITY AND BACKGROUND (a) The names of the persons filing this Schedule 13D are Interinvest Corporation Inc., a Massachusetts corporation; Interinvest (Bermuda) Ltd., a Bermuda corporation; Interinvest Consulting Corporation of Canada Limited, a Canadian corporation; and Hans P. Black, a citizen of Canada. The foregoing persons are hereinafter sometimes referred to collectively as the "Reporting Persons". (b) The principal business address of Interinvest Corporation Inc. is 192 South Street, Suite 350, Boston, MA 02111. The principal business address of Interinvest (Bermuda) Ltd. is 77 Front Street, 3rd Floor, Hamilton HM 12. The principal business address of Interinvest Consulting Corporation of Canada Limited is 3655 rue Redpath, Montreal, QC H3G 2W8. The principal business address of Hans P. Black is 3655 rue Redpath, Montreal, QC H3G 2W8. (c) The principal business of the Reporting Persons is the furnishing of investment advisory services. The principal occupation of Hans P. Black is serving as Chairman of Interinvest Consulting Corporation of Canada Limited and Interinvest Corporation Inc. (d) During the last five years, none of the foregoing entities have been convicted in a criminal proceeding. (e) During the last five years, none of the foregoing entities have been subject to a civil proceeding of the type specified in Items 2(d) or (e) of Schedule 13D. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION The Reporting Persons have acquired an aggregate of 5,295,850 shares of Common Stock for an aggregate purchase price of approximately $4,990,502. The source of funds for such transactions was derived from investment advisory client accounts and personal funds, as well as from positions held by new client of the firms since the last filing. ITEM 4. PURPOSE OF TRANSACTION The Reporting Persons acquired the Common Stock of the Issuer for investment purposes. The Reporting Persons have had, and from time to time may continue to have discussions with management, other shareholders, and third parties regarding matters relating to the financial condition, strategy, business, assets, operations, capital structure and strategic plans of the Issuer. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including the Issuer's financial position and strategic direction, the outcome of the discussions referenced above, actions taken by the Board of Directors of the Issuer, price levels of the securities of the Issuer, other investment opportunities available to the Reporting Persons, conditions in the capital markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investments in the Issuer as they deem appropriate, including purchasing additional securities of the Issuer, selling some or all of the Reporting Persons' respective holdings in the Issuer and/or otherwise changing their intention with respect to any and all matters referred to in Item 4 of Schedule 13D. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER (a) The Reporting Persons beneficially own 5,295,850 shares of Common Stock representing 6.22% of all of the outstanding shares of Common Stock. The percentage set forth in this response is based on the 85,121,983 shares of Common Stock outstanding as of November 5, 2008, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2008. Of the 5,295,850 purchased by the Reporting Persons on behalf of their clients: Interinvest Corporation Inc. purchased 1,572,150 shares or 1.85% of Issuer's outstanding shares; Interinvest Consulting Corporation of Canada Limited purchased 2,482,700 shares and received 100,000 shares in a client transfer through a client transfer for a total of 3.03% of the Issuer's outstanding shares; and Interinvest (Bermuda) Ltd. purchased 961,000 shares for clients, had 100,000 transfered out for a client and received 100,000 in the account of a new client for a total of 1.25% of the Issuer's outstanding shares. Hans P. Black purchased 80,000 shares or 0.1% of the Issuer's outstanding shares. (b) The Reporting Persons may be deemed to have the shared power to vote or to direct the vote of (and the shared power to dispose of or direct the disposition of) the 5,295,850 shares of Common Stock held. This power is shared with the Reporting Persons' investment advisory clients where applicable. Hans P. Black, by virtue of his relationship to each of Interinvest Corporation Inc., Interinvest Consulting Corporation of Canada Limited, and Interinvest (Bermuda) Ltd. may be deemed to indirectly beneficially own 5,215,850 shares of Common Stock. Hans P. Black disclaims beneficial ownership of such Common Stock for all other purposes. (c) The following describes all the transactions in Common Stock that were effected during the past sixty days by the Reporting Persons: Transaction Numberof Price/ Type of Date Shares Cost Share Transaction Interinvest Corporation Inc. 12/23/2008 5,000 $ 884 $0.18 Buy 12/24/2008 20,000 $8,962 $0.45 Buy 12/30/2008 110,000 $43,285 $0.39 Buy 1/7/2009 47,500 $18,739 $0.39 Buy 1/8/2009 10,000 $3,451 $0.35 Buy 1/9/2009 43,600 $15,745 $0.36 Buy 1/15/2009 18,000 $6,592 $0.37 Buy 1/21/2009 50,000 $19,460 $0.39 Buy 1/22/2009 36,900 $11,812 $0.32 Buy 1/26/2009 20,000 $8,096 $0.40 Buy 1/29/2009 30,000 $16,350 $0.55 Buy Interinvest (Bermuda) Ltd. 12/12/2008 -100,000 $16,027 $0.16 Transfer Out 12/29/2008 70,000 $23,602 $0.34 Buy 1/22/09 100,0000$37,500 $0.38 Transfer in new acct Interinvest Consulting Corporation of Canada Limited 12/9/2008 100,000 $17,028 $0.17 Buy 12/12/2008 100,000 $16,027 $0.16 Transfer In 12/18/2008 100,000 $18,262 $0.18 Buy 12/31/2008 32,500 $ 9,557 $0.29 Buy (d) The investment advisory clients of Interinvest Corporation Inc., Interinvest Consulting Corporation of Canada Limited, and Interinvest (Bermuda) Ltd. have the sole right to receive and the sole power to direct the receipt of dividends from, and the proceeds of sale of, any of the Securities beneficially owned by such Reporting Persons on behalf of such clients. No such client has an interest that relates to more than 5% of the Common Stock. (e) Not applicable ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER None of the shares of Common Stock held by the Reporting Persons have been pledged or are otherwise subject to a contingency the occurrence of which would give a third party voting power or investment power over the Common Stock. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS Exhibit 99.1 Joint Filing Agreement, dated as of December 12, 2008 among Interinvest Corporation Inc., Interinvest Consulting Corporation of Canada Limited, Interinvest (Bermuda) Ltd., and Hans P. Black SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 30, 2009 Interinvest Corporation Inc. By: /s/ Stanley T. Schmidt Stanley T. Schmidt President,Interinvest Corporation Inc. Interinvest Corporation of Canada Limited By: /s/ Hans P. Black Hans P. Black Chairman Interinvest (Bermuda) Limited By: /s/ Hans P. Black Hans P. Black Director By: /s/ Hans P. Black Hans P. Black EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with the Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing, along with all other such undersigned, on behalf of the Reporting Persons (as defined in the joint filing), of a statement on Schedule D (including amendments thereto) with respect to the common stock of the Issuer (as defined in the attached Schedule 13D), and agrees that this agreement be included as an exhibit to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. IN WITNESS WHEREOF, each of the undersigned has executed this agreement as of this 12th day of December, 2008. Interinvest Corporation, Inc. By: /s/ Stanley T. Schmidt Stanley T. Schmidt President Interinvest Corporation of Canada Limited By: /s/ Hans P. Black Hans P. Black Chairman Interinvest (Bermuda) Limited By: /s/ Hans P. Black Hans P. Black Director By: /s/ Hans P. Black Hans P. Black CUSIP No. 034918102 Page 9 of 10